| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5700218 | Clinical Oncology | 2006 | 6 Pages |
Abstract
Although the role of combination treatment with pelvic EBRT and androgen therapy is not clear, our early results show that many patients with intermediate- and high-risk disease have excellent results with brachytherapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
S.J. Khaksar, S.E.M. Langley, D. Lovell, R.W. Laing,